US Patent 10370431 Optimized factor VIII gene
Patent 10370431 was granted and assigned to Bioverativ on August, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 14, 2014
0
Date of Patent
August 6, 2019
0
Patent Applicant
Patent Application Number
14767425
0
Patent Citations Received
Patent Inventor Names
Robert T. Peters
0
Siyuan Tan
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10370431 Optimized factor VIII gene
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.